The international effort: building the bridge for Translational Medicine: Report of the 1st International Conference of Translational Medicine (ICTM).
BACKGROUND
Supported by the International Society for Translational Medicine (ISTM), Wenzhou Medical College and the First Affiliated Hospital of Wenzhou Medical College, the International Conference on Translational Medicine (ICTM) was held on October 22-23, 2011 in Wenzhou, China. Nearly 800 registrants attended the meeting, primarily representing institutes and hospitals in Europe, The United States of America, And Asia, and China. The meeting was chaired and organized by Dr. Xiangdong Wang, Xiaoming Chen, Richard Coico, Jeffrey M. Drazen, Richard Horton, Francesco M. Marincola, Laurentiu M. Popescu, Jia Qu and Aamir Shahzad.


RESULTS
The meeting focused on the communication of the need to foster translational medicine (TM) by building and broadening bridges between basic research and clinical studies at the international level. The meeting included distinguished TM experts from academia, the pharmaceutical and diagnostics industries, government agencies, regulators, and clinicians and provided the opportunity to identify shared interests and efforts for collaborative approaches utilizing cutting edge technologies, innovative approaches and novel therapeutic interventions. The meeting defined the concept of TM in its two-way operational scheme and emphasized the need for bed to bench efforts based directly on clinical observation.


CONCLUSIONS
It was the meeting participants' realization that the shared main goals of TM include breaking the separation between clinic practice and basic research, establishing positive feedback by understanding the basis of expected and unexpected clinical outcomes and accelerating basic research relevant to human suffering. The primary objectives of the meeting were two-fold: to accelerate the two-way translation by informing the participants representing the different disciplines about the state of art activities around TM approaches; and to identify areas that need to be supported by redirecting limited resources as well as identifying new sources of funding. This report summarizes key concepts presented during the meeting representing the state-of-art translational research and salient aspects of the ensuing discussions.
Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Center for Human Immunology (CHI), NIH, Bethesda MD, USA. ewang@mail.nih.gov.
Xiaoming
X
Chen
Roland
R
Andersson
William Cs
WC
Cho
David
D
Christiani
Richard
R
Coico
Jeffery
J
Drazen
Markus
M
Ege
Thomas
T
Fehniger
Hongwei
H
Gao
Kunlin
K
Jin
Michael N
MN
Liebman
Elena
E
Lopez
Giuseppe
G
Marraro
Gyorgy
G
Marko-Varga
Francesco M
FM
Marincola
Laurentiu M
LM
Popescu
Claudio
C
Spada
Aamir
A
Shahzad
Ena
E
Wang
Wei
W
Wang
Xiangdong
X
Wang
Yong-Xiao
YX
Wang
Jinglin
J
Xia
Jia
J
Qu